| 33430-62-5

• 物质功能分类: 生物化工 - 核苷类药物 - 核苷酸及其类似物
• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘧啶核苷酸
• CAS: 33430-62-5
• 化学式: C10H15N2NaO8P
• 分子量: 345.2
• InChiKey: YDRKIYXHTAGJRY-HNPMAXIBSA-N

物化性质

• 熔点：
  >300 C
• 溶解度：
  PBS (pH 7.2)：微溶

计算性质

• 辛醇/水分配系数(LogP)：
  -1.78
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  146
• 氢给体数：
  4
• 氢受体数：
  8

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  29349990
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

制备方法与用途

生物活性

Thymidine-5'-monophosphate（5'-胸苷酸）二钠盐是一种具有生物活性的内源性代谢物。

文献信息

• PERFLUOROALKYL-SUBSTITUTED AMINO ACID OLIGOMERS OR POLYMERS AND THEIR USE AS FOAM STABILIZERS IN AQUEOUS FIRE-FIGHTING-FOAM AGENTS AND AS OIL REPELLENT PAPER AND TEXTILE FINISHES
  申请人：Ciba Specialty Chemicals Holding Inc.

  公开号：EP1153061A1

  公开（公告）日：2001-11-14
• Cell culture medium
  申请人：Genetix Limited

  公开号：EP1818392B1

  公开（公告）日：2010-08-25
• HYDROGEL A BASE DE POLYSACCHARIDES NATIFS ET/OU FONCTIONNALISES, PHOSPHATES CO-RETICULES
  申请人：Ayawane

  公开号：EP2989128A1

  公开（公告）日：2016-03-02
• CELL CULTURE MEDIUM
  申请人：Bramke Irene

  公开号：US20110104754A1

  公开（公告）日：2011-05-05

  We describe a method of growing an animal cell in a culture medium, in which the culture medium comprises an elevated concentration of a thymidine family member, in which the growth or viability of the animal cell is increased as a result of the elevated concentration of the thymidine family member in the cell culture medium. Preferably, the cell culture medium comprises a semi-solid medium, which is a serum free or chemically defined medium.
• NUCLEIC ACID-MEDIATED SHAPE CONTROL OF NANOPARTICLES
  申请人：of Trustees of the University of Illinois The Board

  公开号：US20130095039A1

  公开（公告）日：2013-04-18

  Embodiments of a method to use nucleic acid oligomer sequences for modulating the shape of nanoparticles are disclosed, as well as nanoparticles and methods of using the nanoparticles. Systematic variations of the nucleic acid sequences offer mechanistic insights into the morphology control. A plurality of nucleic acid oligomers is adsorbed onto a metal nanoseed to provide an oligomer-functionalized nanoparticle. Additional metal is deposited onto the oligomer-functionalized nanoparticle to produce a shaped nanoparticle having a morphology based at least in part on the nanoseed morphology and the oligomer's sequence composition. Embodiments of methods for using the shaped nanoparticles also are disclosed.